234 related articles for article (PubMed ID: 18715915)
1. Three-dimensional organization of Rift Valley fever virus revealed by cryoelectron tomography.
Freiberg AN; Sherman MB; Morais MC; Holbrook MR; Watowich SJ
J Virol; 2008 Nov; 82(21):10341-8. PubMed ID: 18715915
[TBL] [Abstract][Full Text] [Related]
2. Single-particle cryo-electron microscopy of Rift Valley fever virus.
Sherman MB; Freiberg AN; Holbrook MR; Watowich SJ
Virology; 2009 Apr; 387(1):11-5. PubMed ID: 19304307
[TBL] [Abstract][Full Text] [Related]
3. Electron cryo-microscopy and single-particle averaging of Rift Valley fever virus: evidence for GN-GC glycoprotein heterodimers.
Huiskonen JT; Overby AK; Weber F; Grünewald K
J Virol; 2009 Apr; 83(8):3762-9. PubMed ID: 19193794
[TBL] [Abstract][Full Text] [Related]
4. Risk analysis of inter-species reassortment through a Rift Valley fever phlebovirus MP-12 vaccine strain.
Ly HJ; Lokugamage N; Nishiyama S; Ikegami T
PLoS One; 2017; 12(9):e0185194. PubMed ID: 28926632
[TBL] [Abstract][Full Text] [Related]
5. An assembly model of rift valley Fever virus.
Rusu M; Bonneau R; Holbrook MR; Watowich SJ; Birmanns S; Wriggers W; Freiberg AN
Front Microbiol; 2012; 3():254. PubMed ID: 22837754
[TBL] [Abstract][Full Text] [Related]
6. Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments.
Ikegami T; Hill TE; Smith JK; Zhang L; Juelich TL; Gong B; Slack OA; Ly HJ; Lokugamage N; Freiberg AN
J Virol; 2015 Jul; 89(14):7262-76. PubMed ID: 25948740
[TBL] [Abstract][Full Text] [Related]
7. Expression of Rift Valley fever virus N-protein in Nicotiana benthamiana for use as a diagnostic antigen.
Mbewana S; Meyers AE; Weber B; Mareledwane V; Ferreira ML; Majiwa PAO; Rybicki EP
BMC Biotechnol; 2018 Dec; 18(1):77. PubMed ID: 30537953
[TBL] [Abstract][Full Text] [Related]
8. Structure of the Rift Valley fever virus nucleocapsid protein reveals another architecture for RNA encapsidation.
Raymond DD; Piper ME; Gerrard SR; Smith JL
Proc Natl Acad Sci U S A; 2010 Jun; 107(26):11769-74. PubMed ID: 20547879
[TBL] [Abstract][Full Text] [Related]
9. An equine herpesvirus type 1 (EHV-1) vector expressing Rift Valley fever virus (RVFV) Gn and Gc induces neutralizing antibodies in sheep.
Said A; Elmanzalawy M; Ma G; Damiani AM; Osterrieder N
Virol J; 2017 Aug; 14(1):154. PubMed ID: 28807043
[TBL] [Abstract][Full Text] [Related]
10. Structure of Rift Valley Fever Virus RNA-Dependent RNA Polymerase.
Wang X; Hu C; Ye W; Wang J; Dong X; Xu J; Li X; Zhang M; Lu H; Zhang F; Wu W; Dai S; Wang HW; Chen Z
J Virol; 2022 Feb; 96(3):e0171321. PubMed ID: 34787453
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of a recombinant Rift Valley fever virus MP-12 with NSm deletion as a vaccine candidate in sheep.
Weingartl HM; Nfon CK; Zhang S; Marszal P; Wilson WC; Morrill JC; Bettinger GE; Peters CJ
Vaccine; 2014 Apr; 32(20):2345-9. PubMed ID: 24462482
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of pathogenic Rift Valley fever virus strain through the chimeric S-segment encoding sandfly fever phlebovirus NSs or a dominant-negative PKR.
Nishiyama S; Slack OA; Lokugamage N; Hill TE; Juelich TL; Zhang L; Smith JK; Perez D; Gong B; Freiberg AN; Ikegami T
Virulence; 2016 Nov; 7(8):871-881. PubMed ID: 27248570
[TBL] [Abstract][Full Text] [Related]
13. [Study on DNA immune of envelope protein gene of Rift Valley Fever Virus].
Wang QH; Wang XJ; Hu S; Ge JY; Bu ZG
Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):677-81. PubMed ID: 17944371
[TBL] [Abstract][Full Text] [Related]
14. Development and characterization of a Rift Valley fever virus cell-cell fusion assay using alphavirus replicon vectors.
Filone CM; Heise M; Doms RW; Bertolotti-Ciarlet A
Virology; 2006 Dec 5-20; 356(1-2):155-64. PubMed ID: 16945399
[TBL] [Abstract][Full Text] [Related]
15. Four-segmented Rift Valley fever virus-based vaccines can be applied safely in ewes during pregnancy.
Wichgers Schreur PJ; van Keulen L; Kant J; Kortekaas J
Vaccine; 2017 May; 35(23):3123-3128. PubMed ID: 28457675
[TBL] [Abstract][Full Text] [Related]
16. An alphavirus replicon-derived candidate vaccine against Rift Valley fever virus.
Heise MT; Whitmore A; Thompson J; Parsons M; Grobbelaar AA; Kemp A; Paweska JT; Madric K; White LJ; Swanepoel R; Burt FJ
Epidemiol Infect; 2009 Sep; 137(9):1309-18. PubMed ID: 19171081
[TBL] [Abstract][Full Text] [Related]
17. Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene.
Ikegami T; Won S; Peters CJ; Makino S
J Virol; 2006 Mar; 80(6):2933-40. PubMed ID: 16501102
[TBL] [Abstract][Full Text] [Related]
18. Rift Valley fever virus incorporates the 78 kDa glycoprotein into virions matured in mosquito C6/36 cells.
Weingartl HM; Zhang S; Marszal P; McGreevy A; Burton L; Wilson WC
PLoS One; 2014; 9(1):e87385. PubMed ID: 24489907
[TBL] [Abstract][Full Text] [Related]
19. Molecular aspects of Rift Valley fever virus and the emergence of reassortants.
Gaudreault NN; Indran SV; Balaraman V; Wilson WC; Richt JA
Virus Genes; 2019 Feb; 55(1):1-11. PubMed ID: 30426314
[TBL] [Abstract][Full Text] [Related]
20. Mechanistic Insight into the Host Transcription Inhibition Function of Rift Valley Fever Virus NSs and Its Importance in Virulence.
Terasaki K; Ramirez SI; Makino S
PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005047. PubMed ID: 27711108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
